FDA Approves Phase II Of U-M Stem Cell Trial For ALS For nearly two years, University of Michigan neurologist Eva Feldman, M.D., has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig's disease.
Michigan Women Break World Record Swimming The English ChannelAn amazing story of courage and determination has resulted in a new world record.
ALS Patients Approved For More Stem CellsThree patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan's Eva Feldman, M.D.
Synthetic Biologics Launches Free Investor Relations Mobile ApplicationSynthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the "SYN IR" App, now available for free at the Apple App Store on the iPhone or iPad or at http://bit.ly/I9xDpW.
UM Part Of New Study Of Stem Cell Injections in Lou Gehrig's DiseaseThe first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig's disease, opening the door for further research on this innovative approach.
Adeona Names New Managers, Eyes Name ChangeAdeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig's disease. It's also considering a new business focus and a name change.
Adeona Reports Positive Study Results For Zinc Treatment Of ALSPharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig's Disease
Adeona Loss Grows, But Drug Trials ContinueThe pharma startup Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, reported its third quarter 2011 financial results Monday.
Hundreds To Walk For ALS FundraiserHundreds of people across southeast Michigan are going to "Walk and Roll" for ALS on Sunday at Kensington Metropark in Milford and Stony Creek Metropark in Shelby Township.
Adeona Loss Grows, But Milestones ReachedAnn Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.
Stem Cell Research Aims To Help Lou Gehrig's Patients Promising new research at the University of Michigan that could bring new hope to those suffering from Lou Gehrig's disease.
Finger Size And Lou Gehrig's DiseaseDo your fingers hold a clue about Lou Gehrig's disease? Possibly.
A Real Life Action Hero!Here's your chance to meet a real life action hero. Jim Hiller will be honored Thursday, April 28, in a benefit for ALS of Michigan.
Stem Cell Summit: Cure For Paralysis And More?
Stem Cell Cures On Horizon, UM Scientists Say